Related references
Note: Only part of the references are listed.A 45-year experience of uveal melanoma in Taiwan: Verification of American Joint Committee on Cancer staging system and prognostic factors
Shang-Te Ma et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Inflammatory Cell Differentiation and Chemotaxis and Extracellular Tissue Repair Markers Are Correlated with Pulmonary Dysfunction in HIV Infected Individuals Presenting with Community-Acquired Pneumonia
Ruochen Mao et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2020)
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
Michael A. Durante et al.
NATURE COMMUNICATIONS (2020)
Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region
Sarah E. Coupland et al.
JAMA OPHTHALMOLOGY (2020)
BAFF attenuates oxidative stress-induced cell death by the regulation of mitochondria membrane potential via Syk activation in WiL2-NS B lymphoblasts
Sojin Park et al.
SCIENTIFIC REPORTS (2020)
Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma
Yamini Krishna et al.
CANCERS (2020)
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
Sophie Piperno-Neumann et al.
CANCERS (2019)
Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes
Pierre L. Triozzi et al.
ONCOIMMUNOLOGY (2019)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li et al.
CELL (2019)
BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca2+ -CaMKII-dependent Akt/mTOR signaling pathway in normal and neoplastic B-lymphoid cells
Xiaoqing Dong et al.
CELLULAR SIGNALLING (2019)
BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
Vasiliki Pelekanou et al.
FRONTIERS IN ONCOLOGY (2018)
BAFF and BAFF-Receptor in B Cell Selection and Survival
Cristian R. Smulski et al.
FRONTIERS IN IMMUNOLOGY (2018)
Metastatic disease from uveal melanoma: treatment options and future prospects
Richard D. Carvajal et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
Benjamin A. Krantz et al.
CLINICAL OPHTHALMOLOGY (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
Systemic inflammation before and after antiretroviral therapy initiation as a predictor of immune response among HIV-infected individuals in Manitoba
Quinlan Richert et al.
CYTOKINE (2017)
The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status
Mehmet Dogrusoz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Insights into genetic alterations of liver metastases from uveal melanoma
Conni McCarthy et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Uveal melanoma: From diagnosis to treatment and the science in between
Chandrani Chattopadhyay et al.
CANCER (2016)
Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients
Ayseguel Tura et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer
Hengli Dou et al.
ONCOLOGY LETTERS (2016)
APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer
Araceli Garcia-Castro et al.
CARCINOGENESIS (2015)
Uveal melanoma: Estimating prognosis
Swathi Kaliki et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2015)
Clinical Characteristics of 582 Patients with Uveal Melanoma in China
Yue Ming Liu et al.
PLOS ONE (2015)
BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma
L. Bolkun et al.
ANNALS OF HEMATOLOGY (2014)
Identification of Circulating Melanoma Cells in Uveal Melanoma Patients by Dual-Marker Immunoenrichment
Ayseguel Tura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells
Tingting Long et al.
CANCER LETTERS (2013)
Increased B Cell-Activating Factor Promotes Tumor Invasion and Metastasis in Human Pancreatic Cancer
Mitsuhito Koizumi et al.
PLOS ONE (2013)
Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
Anthony E. Rizzardi et al.
DIAGNOSTIC PATHOLOGY (2012)
GDF-15: a novel serum marker for metastases in uveal melanoma patients
Daniela Suesskind et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
Matthias Kreuzaler et al.
JOURNAL OF IMMUNOLOGY (2012)
Different Subsets of Tumor-Infiltrating Lymphocytes Correlate with Macrophage Influx and Monosomy 3 in Uveal Melanoma
Inge H. G. Bronkhorst et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Plasma Markers for Identifying Patients with Metastatic Melanoma
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2011)
Functional and Clinical Aspects of the B-Cell-Activating Factor (BAFF): A Narrative Review
G. A. Lied et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival
Inge H. G. Bronkhorst et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
BAFF-R promotes cell proliferation and survival through interaction with IKKβ and NF-κB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells
Lingchen Fu et al.
BLOOD (2009)
APRIL is overexpressed in cancer: link with tumor progression
Jerome Moreaux et al.
BMC CANCER (2009)
Osteopontin and 'Melanoma Inhibitory Activity': Comparison of Two Serological Tumor Markers in Metastatic Uveal Melanoma Patients
Ingrid Haritoglou et al.
OPHTHALMOLOGICA (2009)
Molecular pathways mediating liver metastasis in patients with uveal melanoma
Silvin Bakalian et al.
CLINICAL CANCER RESEARCH (2008)
Cytogenetics of uveal melanoma - A 7-year clinical experience
Bertil Damato et al.
OPHTHALMOLOGY (2007)
Presence and phenotype of dendritic cells in uveal melanoma
Marta E. Polak et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Osteopontin as a serologic marker for metastatic uveal melanoma:: Results of a pilot study
Ingrid Wanke Reiniger et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Osteopontin expression and serum levels in metastatic uveal melanoma: A pilot study
SS Kadkol et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Melanoma inhibitory activity (MIA): a promising serological tumour marker in metastatic uveal melanoma
IW Reiniger et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2005)
Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction
U Keilholz et al.
CLINICAL CANCER RESEARCH (2004)
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway
C Kern et al.
BLOOD (2004)
B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers
ZSM Rahman et al.
JOURNAL OF IMMUNOLOGY (2004)
Prognostic value of S-100-β serum concentration in patients with uveal melanoma
GSOA Missotten et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
BAFF: A fundamental survival factor for B cells
F Mackay et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
